Veterinary CRO & CDMO Market Size is valued at USD 1475.63 Mn in 2024 and is predicted to reach USD 118868.03 Mn by the year 2034 at 55.2% CAGR during the forecast period for 2025-2034.
Both Veterinary CROs and CDMOs play a collaborative role in advancing veterinary medicine, offering expertise, resources, and infrastructure that enable the efficient and effective development of new treatments and health products for animals. By partnering with these organizations, veterinary product developers can accelerate the time to market for new therapies, contributing to animal health and welfare while also addressing the needs of the veterinary market. These organizations provide a variety of services, including preclinical and clinical studies, regulatory support, formulation development, and commercial-scale manufacturing of veterinary pharmaceuticals. The veterinary CRO and CDMO industry has expanded significantly due to rising demand for safe and effective veterinary pharmaceuticals, the requirement for regulatory compliance, and increased investment in animal healthcare. These organizations play a critical role in veterinary pharmaceutical development, ensuring their safety and efficacy, and assisting corporations in navigating the veterinary industry's complex regulatory structure.
The veterinary CRO and CDMO market is being pushed by rising awareness of animal health and welfare, severe regulatory requirements, and a need for specialized services. Rising pet ownership, improved livestock production, and the prevalence of zoonotic diseases have all contributed to increased investment in veterinary pharmaceutical research and development. Stringent safety and efficacy criteria have increased demand for specialized services. Advances in veterinary medicine and technology have offered prospects for novel medicines, accelerating market growth. Pharmaceutical companies and CRO/CDMOs can collaborate strategically to create drugs at a lower cost and with greater efficiency. Overall, these aspects contribute to the market's growth.
The Veterinary CRO & CDMO Market is segmented by animal type, application type and service type,. Based on animal type, the market is segrigated into companion and livestock animals. By application type, the market is segmented into medicine and medical devices. By service type, the market is segmented into discovery, development, manufacturing, packaging & labeling, and market approval & post-marketing.
The livestock animal segment led the business in 2022, accounting for 40.4% of total revenue because to the high production rate of vaccinations, medicines, and infectious disease diagnostic goods aimed primarily at food-producing animals. The dominant share is also attributed to rising protein consumption, milk or meat requirements, and expanding live animal markets worldwide. Furthermore, rising zoonotic concerns and increased spending on livestock animals are driving the demand for CROs and CDMOs to support huge medication production.
The medical devices segment is estimated to increase at the quickest CAGR throughout the forecast period. Rising technical breakthroughs in veterinary diagnostics, rising animal healthcare expenditure, and the widespread availability of contract veterinary equipment manufacturers and raw material suppliers are driving segment expansion. Furthermore, corporations are investing more in expanding their production capacity through the use of broad networks of CROs and CDMOs, which has a beneficial impact on and supports subsequent growth rates.
North America dominated the animal health CRO & CDMO market, accounting for more than 30% of total revenue. This considerable share can be attributable to the strong presence of important companies coupled with the rising number of drug development and veterinary product launch activities in the region. Rising veterinary clinical trial activities in the United States, increased availability of contract organizations in veterinary product development, improved manufacturing infrastructure in the region's developed countries, and increasing animal healthcare investments all contribute to market growth. The Asia Pacific area would exhibit the quickest CAGR during the predicted period. This is primarily due to the region's attractiveness, as well as the low-cost and flexible sourcing provided by large networks of veterinary outsourcing companies. Countries, like China and India, have been dominating in medical outsourcing for some years; moreover, recently, Southeast Asian countries, like Philippines, Malaysia, Indonesia, and Vietnam, are garnering market attention with significant potential. Similarly, popular destinations for veterinary outsourcing activities include Latin America, the Middle East, and Africa.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 55.2% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Animal Type, Application Type, Service Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Aare Labcorp Drug Development, Charles River Laboratories, Clinvet, Klifovet GmbH, Oncovet Clinical Research (OCR), Knoell Triveritasm, Vetspin, Inotiv, Idexx Laboratories, Zoetis Nexvet, PAREXEL International Corporation, ICON plc, Pharmaceutical Product Development, LLC (PPD), Syneos Health, WuXi AppTec, Medpace, Envigo, Vetio Animal Health, Clinipace, MPI Research, Veterinary Research Management (VRM), VetPharm, Inc., Merck Animal Health and others. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Veterinary CRO & CDMO Market By Animal Type -
Veterinary CRO & CDMO Market By Application Type -
Veterinary CRO & CDMO Market By Service Type -
Veterinary CRO & CDMO Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.